Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVADEL PHARMACEUTICALS PLC Director's Dealing 2018

Jul 27, 2018

31920_dirs_2018-07-27_37bda352-7fe6-4715-b726-02fea26f7f69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2018-07-18

Reporting Person: Palczuk Linda (Director)